Cite
Chang Y, Kim SG, Jeong SW, et al. Efficacy and Safety of Tenofovir Disoproxil Orotate in Chronic Hepatitis B Patients Previously Treated with Tenofovir Disoproxil Fumarate: Multicenter, Open-Label, Prospective Study. J Clin Med. 2021;10(23)doi: 10.3390/jcm10235628.
Chang, Y., Kim, S. G., Jeong, S. W., Jang, J. Y., Yoo, J. J., Lee, S. H., Kim, Y. S., Kim, H. S., Lee, H. W., & Park, S. (2021). Efficacy and Safety of Tenofovir Disoproxil Orotate in Chronic Hepatitis B Patients Previously Treated with Tenofovir Disoproxil Fumarate: Multicenter, Open-Label, Prospective Study. Journal of clinical medicine, 10(23), . https://doi.org/10.3390/jcm10235628
Chang, Young, et al. "Efficacy and Safety of Tenofovir Disoproxil Orotate in Chronic Hepatitis B Patients Previously Treated with Tenofovir Disoproxil Fumarate: Multicenter, Open-Label, Prospective Study." Journal of clinical medicine vol. 10,23 (2021). doi: https://doi.org/10.3390/jcm10235628
Chang Y, Kim SG, Jeong SW, Jang JY, Yoo JJ, Lee SH, Kim YS, Kim HS, Lee HW, Park S. Efficacy and Safety of Tenofovir Disoproxil Orotate in Chronic Hepatitis B Patients Previously Treated with Tenofovir Disoproxil Fumarate: Multicenter, Open-Label, Prospective Study. J Clin Med. 2021 Nov 29;10(23). doi: 10.3390/jcm10235628. PMID: 34884330.
Copy
Download .nbib